Study of Serum and Tissues Angiotensin Converting Enzyme (ACE) Activity in Rat with Gentamicin Induced Renal Toxicity

Renal Failure

Volumn 25, Issue 6, 2003, Pages 923-933

  Ziai, Seyed Ali ^a   Salehian, Pirooz ^a   Mahmoudian, Massoud ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiotensin converting enzyme; Blood pressure; Gentamicin; Rat; Tubular necrosis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENTAMICIN; N ACETYL BETA GLUCOSAMINIDASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE MODEL; ENZYME ACTIVITY; ENZYMURIA; HISTOLOGY; KIDNEY; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; LUNG; MALE; MICROSCOPY; NEPHROTOXICITY; NONHUMAN; POLYURIA; PRIORITY JOURNAL; PROTEINURIA; RAT; RAT STRAIN; SCORING SYSTEM; SERUM;

ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GENTAMICINS; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; KIDNEY TUBULAR NECROSIS, ACUTE; MALE; PEPTIDYL-DIPEPTIDASE A; PROBABILITY; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY;

EID: 0344394275     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120026027     Document Type: Article

References (48)

1. Corvol, P.; Williams, T.A. Soubrier F: peptidyl dipeptidase A: angiotensin I-converting enzyme. Methods. Enzymol. 1995, 248, 283-305.
2. Letizia, C.; Picarelli, A.; De Ciocchis, A.; Di Glovambattista, F.; Greco, M.; Cerci, S.; Torsoli, A.; Scavo, D. Angiotensin-converting enzyme activity in stools of healthy subjects and patients with celiac disease. Digest. Dis. Sci. 1996, 41, 2268-2271.
3. Takada, Y.; Hiwada, K.; Kokubu, T. Isolation and characterization of angiotensin converting enzyme from human kidney. J. Biochem. 1981, 90, 1309-1319.
4. Ward, P.E.; Sheridan, M.A.; Hammon, K.J.; Erdos, E.G. Angiotensin I converting enzyme (kininase II) of the brush border of human and swine intestine. Biochem. Pharmacol. 1981, 29, 1525-1529.
5. Ikemoto, F.; Song, G.; Tominaga, M.; Kanayama, Y.; Yamamoto, K. Angiotensin-converting enzyme in the rat kidney activity, distribution, and response to angiotensin-converting enzyme inhibitors. Nephron 1990, 55, (suppl I) 3-9.
6. Beldent, V.; Michaud, A.; Wei, L.; Chauvet, M.T.; Corvol, P. Proteolytic release of human angiotensin-converting enzyme: localization of cleavage site. J. Biol. Chem. 1993, 268, 26428-26434.
7. Campbell, D.J. The site of angiotensin production. J. Hypertens. 1985, 3, 199-207.
8. Leiberman, J. Elevation of serum angiotensin converting enzyme (ACE) levels in sarcoidosis. Am. J. Med. 1975, 59, 365-372.
9. Leiberman, J.; Beutler, E. Elevation of serum angiotensin converting enzyme in Gaucher's disease. N. Engl. J. Med. 1976, 294, 1442-1444.
10. Studdy, P.R.; Lapworth, R.; Bird, R. Angiotensin converting enzyme and its clinical significance-a review. J. Clin. Path. 1983, 36, 938-947.
11. Ucar, G.; Yildirim, Z.; Ataol, E.; Erdogan, Y.; Biber, C. Serum angiotensin converting enzyme activity in pulmonary disease: correlation with lung function parameters. Life Sci. 1997, 61, 1075-1082.
12. Lazo, J.S. Angiotensin converting enzyme activity in mice after subacute bleomycin administration. Toxicol. Appl. Pharmacol. 1981, 59, 395-398.
13. Lazo, J.S.; Catravas, J.D.; Gillis, C.N. Reduction in rabbit serum and pulmonary angiotensin converting enzyme activity after subacute bleomycin treatment. Biochem. Pharmacol. 1981, 30, 2577-2581.
14. Hollinger, M.A.; Giri, S.N.; Patwell, S.; Zuckerman, J.E.; Gorin, A.; Parsons, G. Effects of acute lung injury on angiotensin converting enzyme in serum, lung lavage, and effusate. Am. Rev. Respir. Dis. 1980, 121, 373-376.
15. Erman, A.; Chen-Gal, B.; Zabludowski, J.; Rosenfeld, J.B. Cyclosporin A treatment enhances angiotensin converting enzyme activity in lung and serum of rats. J. Pharm. Pharmacol. 1990, 42, 525-527.
16. Pedraza-Chaverri, J.; Ivette Moreno-Muniz, S.; Cruz, C.; Hernandez-Pando, R.; Larriva-Sahd, J.; Tapia, E. Urinary angiotensin I converting enzyme activity is increased in experimental acute renal failure. Clin. Invest. Med. 1995, 18, 424-434.
17. Ziai, S.A.; Mooraki, A.; Mahmoudian, M. Gentamicin reduces serum ACE activity in patients with normal kidney function. Am. J. Nephrol. 2002, 22, 487-490.
18. Shuler, C.L.; Bennett, W.M. Nephropathies caused by drugs, chemicals or physical agents. I. Antimicrobial nephrotoxicity. In Textbook of nephrology; Massry, S.G.; Glassock, R.J. Eds.; Williams & Wilkins: Baltimore, 1995; 930-935.
19. De Broe, M.E.; Paulus, G.J.; Verpooten, G.A.; Roels, F.; Buyssens, N.; Wedeen, R.; Van Hoof, F.; Tulkens, P.M. Early effects of gentamicin, tobramycin, and amikacin on the human kidney. Kidney Int. 1984, 25, 643-652.
20. Morin, J.P.; Viotte, G.; Vandewalle, A.; Van Hoof, F.; Tulkens, P.; Fillastre, J.P. Gentamicin-induced nephrotoxicity: a cell biology approach. Kidney Int. 1980, 18, 583-590.
21. Olier, B.; Morin, J.P.; Grancher, G.; Fillastre, J.P. Regenerating tubular cell process in rat kidney: influence of gentamicin treatment. Int. J. Tiss. React. 1987, 9, 241-250.
22. Plummer, D.T.; Noorazar, S.; Haslam, J.D. The effect of gentamicin and coenzyme Q on the excretion of enzymes and ions in rat urine. In Nephrotoxicity Ototoxcity of Drugs; Fillastre, J.P., Ed.; Colloque INSERM, Universite de Rouen. 1982, 178-194.
23. Hilgers, K.F.; Mann, J.F.E. Role of angiotensin II in glomerular injury: lessons from experimental and clinical studies. Kidney Blood Press. Res. 1996, 19, 254-262.
24. Matsusaka, T.; Hymes, J.; Ichikawa, I. Angiotensin in progressive renal disease: theory and practice. J. Am. Soc. Nephrol. 1996, 7, 2025-2043.
25. Mirkhani, H.; Omrani, G.R.; Ghiaee, S.; Mahmoudian, M. Effects of mebudipine and dibudipine, two new calcium channel blockers, on rat left atrium, rat blood pressure and human internal mammary artery. J. Pharm. Pharmacol. 1999, 51, 617-622.
26. Horiuchi, M.; Fujimura, K.; Trashima, T.; Iso, T. Method for determination of angiotensin-converting enzyme activity in blood and tissue by high-performance liquid chromatography. J. Chromatogr. 1982, 233, 123-130.
27. Whelton, A.; Watson, A.J.; Rock, R.C. Nitrogen metabolites and renal function. In Tietz Textbook of Clinical Chemistry, 2nd Ed.; Burtis, C.A., Ashwood, E.R., Eds.; W. B. Saunders Co.: Philadelphia, 1994; 1528-1539.
28. Silverman, L.M.; Christenson, R.H. Amino acids and proteins. In Tietz Textbook of Clinical Chemistry, 2nd Ed.; Burtis, C.A., Ashwood, E.R., Eds.; W. B. Saunders Co.: Philadelphia, 1994; 719-726.
29. Ziai, S.A.; Sadeghian, T.; Soltani-Arabshahi, S.K.; Mahmoudian, M. Determination of angiotensin converting enzyme (ACE) activity in healthy Iranian population: relationship to paraclinical parameters and cigarette smoking. Res. Commun. Alcohol Subst. Abuse, 1999, 20, 99-111.
30. Horak, E.; Hopfer, S.M.; Sunderman, F.W. Spectrophotometric assay for urinary N-acetyl-β-D-glucosaminidase activity. Clin. Chem. 1981, 27, 1180-1185.
31. Morin, J.P.; Thomas, N.; Toutain, H.; Borghi, H.; Fillastre, J.P. Modulation of gentamicin nephrotoxicity by chronic inhibition of angiotensin I converting enzyme in rat. Arch. Toxicol. 1989, 63, 47-53.
32. Ryan, U.S.; Ryan, J.W.; Whitaker, C.; Chiu, A. Localization of angiotensin converting enzyme (kininase II). II Immunocytochemistry and immunoflorescence. Tissue Cell 1976, 8, 125-145.
33. Soffer, R.L. Angiotensin converting enzyme. In Biochemical Regulation of Blood Pressure; Soffer, R.L. Ed.; Wiley: New York, 1981; 123-164.
34. Caldwell, P.R.B.; Seegal, B.C.; Hsu, K.C. Angiotensin-converting enzyme: vascular endothelial localization. Science 1976, 191, 1050-1051.
35. Erdos, E.G. The angiotensin I converting enzyme. Fed. Proc. 1971, 36, 1760-1765.
36. Erdos, E.G.; Skidgel, R.A. The angiotensin I-converting enzyme. Lab. Invest. 1987, 56, 345-348.
37. Ikemoto, F.; Song, G.; Tominaga, M. Angiotensin converting enzyme predominates in the inner cortex and medulla of the rat kidney. Biochem. Biophys. Res. Commun. 1987, 144, 915-921.
38. Marchetti, J.; Roseau, S.; Alhenc-Gelas, F. Angiotensin I converting enzyme and kinin hydrolyzing enzymes along the rabbit nephron. Kidney Int. 1987, 31, 744-751.
39. Arevalo, A.E.; Ibarra-Rubio, M.E.; Cruz, C.; Pena, J.C.; Pedraza-Chavverri, J. Angiotensin I-converting activity in puromycin aminonucleoside-nephrotic syndrome. Clin. Chim. Acta, 1990, 191, 175-184.
40. Hollinger, M.A. Biochemical evidence for pulmonary endothelial cell injury after carbon tetrachloride administration in mice. J. Pharmacol. Exp. Ther. 1982, 222, 641-644.
41. Hall, E.R.; Kato, J.; Erdos, E.G. Angiotensin I-converting enzyme in the nephron. Life Sci. 1976, 18, 1299-1304.
42. Luft, F.C.; Patel, V.; Yum, M.N.; Patel, B.; Kleit, S.A. Experimental aminoglycoside nephrotoxicity. J. Lab. Clin. Med. 1975, 86, 213-220.
43. Stefanovic, V.; Vlahovic, P.; Savic, V.; Ilic, S.; Mitic-Zlatkovic, M. Kidney ectopeptidases in gentamicin and mercuric chloride-induced acute renal failure. Cell Physiol. Biochem. 1998, 8, 278-284.
44. Zager, R.A.; Prior, R.B. Gentamicin and gram-negative bacteremia. A Synergism for the development of experimental nephrotoxic acute renal failure. J. Clin. Invest. 1986, 78, 196-204.
45. Baylis, C.; Rennke, H.G.; Brenner, B.M. Mechanisms of the defects in glomerular ultrafiltration associated with gentamicin administration. Kidney Int. 1977, 12, 344-353.
46. Klotman, P.E.; Boatman, J.E.; Volpp, B.D.; Baker, J.D.; Yarger, W.E. Captopril enhances aminoglycoside nephrotoxicity in potassium-depleted rats. Kidney Int. 1985, 28, 118-127.
47. Luft, F.C.; Aronoff, G.R.; Evan, A.P.; Connors, B.A.; Weinberger, M.H.; Kleit, S.A. The renin-angiotensin system in aminoglycoside-induced acute renal failure. J. Pharmacol. Exp. Ther. 1982, 220, 433-439.
48. Ujiie, K.; Tomita, K.; Owada, A.; Matsui, N.; Marumo, F. Angiotensin-converting enzyme activity as a prognostic factor in acute renal failure. Nephron 1991, 58, 443-449.